Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dicker

Showing results (311-320 of 375) with videos related to

Pageof 38
Sort By:
The Oncologist|November 30, 2017
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access ProgramOliver Sartor, Nicholas J Vogelzang, Christopher Sweeney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
The Landscape of Prognostic Outlier Genes in High-Risk Prostate CancerShuang G Zhao, Joseph R Evans, Vishal Kothari, et al.
The Canadian Journal of Urology|June 21, 2023
Enhancing bladder cancer care through the multidisciplinary clinic approachJ Ryan Mark, Leonard G Gomella, Costas D Lallas, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyRobert B Den, Felix Y Feng, Timothy N Showalter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
BMJ Open|March 25, 2022
Coeliac plexus radiosurgery for pain management in patients with advanced cancer : study protocol for a phase II clinical trialGalia Jacobson, Ronen Fluss, Amira Dany-BenShushan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent GlioblastomaChristina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
JCO Precision Oncology|June 24, 2021
Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic EvaluationVeda N Giri, Elias Obeid, Laura Gross, et al.
European Urology|January 26, 2016
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical ProstatectomyStephen J Freedland, Voleak Choeurng, Lauren Howard, et al.
Pageof 38

Showing results (311-320 of 375) with videos related to

Sort By:
Pageof 38
The Oncologist|November 30, 2017
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access ProgramOliver Sartor, Nicholas J Vogelzang, Christopher Sweeney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
The Landscape of Prognostic Outlier Genes in High-Risk Prostate CancerShuang G Zhao, Joseph R Evans, Vishal Kothari, et al.
The Canadian Journal of Urology|June 21, 2023
Enhancing bladder cancer care through the multidisciplinary clinic approachJ Ryan Mark, Leonard G Gomella, Costas D Lallas, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyRobert B Den, Felix Y Feng, Timothy N Showalter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
BMJ Open|March 25, 2022
Coeliac plexus radiosurgery for pain management in patients with advanced cancer : study protocol for a phase II clinical trialGalia Jacobson, Ronen Fluss, Amira Dany-BenShushan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent GlioblastomaChristina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
JCO Precision Oncology|June 24, 2021
Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic EvaluationVeda N Giri, Elias Obeid, Laura Gross, et al.
European Urology|January 26, 2016
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical ProstatectomyStephen J Freedland, Voleak Choeurng, Lauren Howard, et al.
Pageof 38